LCTX LINEAGE CELL THERAPEUTICS IN
2026Q1 · CUSIP 53566P109 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
129
Δ holders QoQ
+7
Breadth percentile
Top 37%
Whale holders
58
Δ whales
+3
Inst. holding value
$176M
New positions
25
Closed positions
18
Price momentum (1Q)
-26.2%
Put / Call
1/2
Breadth history (34 quarters)
Past Lit Events & Aftermath 3 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2023Q1 | Top 16% | +0.0% | -28.3% |
| 2022Q3 | Top 18% | — | — |
| 2019Q3 | Top 0% | — | — |
Options Sentiment
Put holders
1
QoQ: -1
Call holders
2
QoQ: 0
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-0.29
EPS YoY
—
Revenue (TTM)
$0.0B
Revenue YoY
+54.6%
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)